Latest from Stock

These prophets of economic doom are worried about another collapse

Washington Post: The current investment boom is triggering deja vu for some economists.

Wall St bets on fourth year of gains as S&P 500 bull run rolls into 2026

All 21 Wall Street strategists surveyed tip the S&P 500 to rise in 2026.

Stock Takes: BlackRock still 'pro-risk' despite talk of AI bubble

BlackRock's unrelenting 'pro-risk' approach, and Vital management goes internal.

Market close: Retirement stocks rise on quiet day for NZ sharemarket

The NZX was up slightly with Ryman and Summerset benefiting from a lull.

Mark Lister: The upside of short-term sharemarket pain

OPINION: Nine market dips of 10% or more have occurred since 2010, lasting three months.

Stock Takes: Can the a2 Milk leopard change its spots?

Dual-listed a2 Milk is becoming an infant formula manufacturer in its own right.

Mark Lister: Why NZ's market isn't really at a record high

OPINION: When dividends are stripped out, the NZX 50 remains 13.9% below its 2021 peak.

Stock Takes: Could F&P Healthcare surprise with better than forecast result?

F&P Healthcare has forecast revenue of $1.075b and net profit of $200m for the half.

Markets slide as Nvidia test looms and Fed doubts grow

Nvidia shares fell 1.9% ahead of its earnings, testing investor confidence.